If you need more lookups,
subscriptions start at $34 USD/month.
Adam Wilkinson Location
Cambridge, GB
Adam Wilkinson Work
VP Pre-Clinical Development @ (January 2019 - Present)
Board Member @ (January 2025 - October 2025)
Director @ AstriBio Limited (April 2016 - December 2018)
Head of R and D @ Phico Therapeutics Ltd. (January 2007 - April 2016)
Molecular Biology Group Leader @ Phico Therapeutics Ltd. (January 2005 - January 2007)
Senior R and D Scientist @ Phico Therapeutics Ltd. (January 2002 - January 2005)
Post Doctoral Scientist @ (January 2000 - January 2002)
Post Doctoral Scientist @ (January 1998 - January 2000)
Adam Wilkinson Education
John Innes Centre, Norwich
PhD (Molecular Microbiology)
1994-1998
University of Reading
Bachelor's degree (Microbiology)
1991-1994
Adam Wilkinson Skills
Biotechnology
Molecular Biology
Microbiology
DNA
GMP
Life Sciences
Drug Development
Drug Design
Lifesciences
Molecular Microbiology
Genetic Engineering
Antibacterial
Antibiotic Resistance
Technology Transfer
Pharmaceutical Industry
Fermentation Process Development
Chromatography
Purification
Molecular Genetics
Biochemistry
Bacteriology
Patent Applications
Project Management
Research and Development (R&D)
Leadership
Cell Culture
Strategic Planning
Microsoft Office
Microsoft Excel
Science
Research and Development R&d
Marketing
Strategy
Chemistry
Research and Development
Genetics
Research
Biopharmaceuticals
Drug Discovery
Patent preparation
Patent Portfolio Management
Adam Wilkinson Summary
Adam Wilkinson, based in Cambridge, GB, is currently a VP Pre-Clinical Development at Microbiotica . Adam Wilkinson brings experience from previous roles at Pharmabiotic Research Institute (PRI), AstriBio Limited and Phico Therapeutics Ltd.. Adam Wilkinson holds a 1994 - 1998 PhD in Molecular Microbiology @ John Innes Centre, Norwich. With a robust skill set that includes Biotechnology, Molecular Biology, Microbiology, DNA, GMP and more. Adam Wilkinson has 2 emails on RocketReach.
Looking for a different Adam Wilkinson?
Find contact details for 700 million professionals.